Fidelity Advisor Health Care Fund - Class A FACDX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 62.55  /  −1.74 %
  • Total Assets 3.2B
  • Adj. Expense Ratio
    0.930%
  • Expense Ratio 0.930%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 52%

USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 4:51 AM GMT+0

Morningstar’s Analysis FACDX

Will FACDX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still an exceptional source of healthcare exposure for the long term.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FACDX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 38.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

8.14 236M
Healthcare

Danaher Corp

6.92 201M
Healthcare

Johnson & Johnson

4.89 142M
Healthcare

Thermo Fisher Scientific Inc

4.31 125M
Healthcare

UnitedHealth Group Inc

3.47 101M
Healthcare

Alnylam Pharmaceuticals Inc

2.44 71M
Healthcare

Gilead Sciences Inc

2.20 64M
Healthcare

Ascendis Pharma AS

2.19 64M
Healthcare

Boston Scientific Corp

2.16 63M
Healthcare

AbbVie Inc

2.10 61M
Healthcare

Sponsor Center